Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clinical Genomics Laboratory, |
RCV005052244 | SCV005685328 | uncertain significance | Hennekam lymphangiectasia-lymphedema syndrome 2 | 2024-10-08 | criteria provided, single submitter | clinical testing | A FAT4 c.14009G>A (p.Gly4670Glu) variant was identified at a heterozygous allelic fraction of 50.6%, a frequency which may be consistent with germline origin. This variant, to our knowledge, has not been reported in the medical literature and is only observed on 1/1,614,102 alleles in the general population (gnomAD v.4.1.0), indicating it is not a common variant. Computational predictors are uncertain as to the impact of this variant on FAT4 function. Due to limited information, and based on ACMG/AMP guidelines for variant interpretation (Richards S et al., PMID: 25741868), the clinical significance of this variant is uncertain at this time. |